Manhattan Bridge Capital, Inc. Reports Third Quarter Results for 2026

GREAT NECK, N.Y., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Manhattan Bridge Capital, Inc. (Nasdaq: LOAN) (the “Company”) announced today that its total revenues for the three months ended September 30, 2026 were approximately $2,054,000, compared to approximately $2,036,000 for the same period in 2025, representing an increase of approximately $18,000, or 0.9%. The increase was primarily attributable to higher origination fees, partially offset by lower interest income resulting from lower interest rates charged to borrowers due to increased competition in the marketplace. For the three months ended September 30, 2026 and 2025, approximately $1,662,000 and $1,770,000, respectively, of the Company’s revenues were attributable to interest income on secured commercial loans offered to real estate investors, and approximately $392,000 and $265,000, respectively, of the Company’s revenues were attributable to origination fees on such loans. The loans are principally secured by real estate collateral and accompanied by personal guarantees from the principals of the borrowers.

Net income for the three months ended September 30, 2026 was approximately $1,238,000, or $0.11 per basic and diluted share (based on approximately 11.41 million weighted-average outstanding common shares), compared to approximately $1,202,000, or $0.11 per basic and diluted share (based on approximately 11.44 million weighted-average outstanding common shares), for the same period in 2025, representing an increase of approximately $36,000, or 3.0%. The increase was primarily attributable to lower interest expense and higher origination fee income, partially offset by lower interest income and higher general and administrative expenses.

Total revenues for the nine months ended September 30, 2026 were approximately $6,166,000, compared to approximately $6,665,000 for the same period in 2025, representing a decrease of approximately $499,000, or 7.5%. The decrease occurred despite increases in both the number of loans originated and the amount of capital deployed and was primarily attributable to lower interest rates and origination fees charged to borrowers as a result of increased competition in the marketplace. For the nine months ended September 30, 2026 and 2025, approximately $5,099,000 and $5,504,000, respectively, of the Company’s revenues were attributable to interest income on secured commercial loans offered to real estate investors, and approximately $1,067,000 and $1,161,000, respectively, were attributable to origination fees on such loans. The loans are principally secured by real estate collateral and accompanied by personal guarantees from the principals of the borrowers.

Net income for the nine months ended September 30, 2026 was approximately $3,665,000, or $0.32 per basic and diluted share (based on approximately 11.42 million weighted-average outstanding common shares), compared to approximately $3,988,000, or $0.35 per basic and diluted share (based on approximately 11.44 million weighted-average outstanding common shares), for the same period in 2025, representing a decrease of approximately $323,000, or 8.1%. The decrease was primarily attributable to lower revenues and higher general and administrative expenses, partially offset by lower interest expense.

As of September 30, 2026, total shareholders' equity was approximately $42,789,000.

On November 20, 2025, the Company’s board of directors authorized a share repurchase program authorizing the repurchase of up to 100,000 shares of the Company’s common stock in the next twelve months. As of September 30, 2026, the Company had repurchased an aggregate of 61,185 shares under the program at a total cost of approximately $248,000. Of these amounts, 54,985 shares were repurchased during the nine months ended September 30, 2026 at an aggregate cost of approximately $219,000.

On October 8, 2026, the Company’s board of directors approved an amendment to the existing share repurchase program, increasing the aggregate number of shares authorized for repurchase from 100,000 to 250,000 shares and extending the program for an additional 12 months, through October 8, 2027.

Assaf Ran, Chairman of the Board and Chief Executive Officer of the Company, stated, “The increasing interest rate environment is raising pressure on the real estate markets, rent-to-mortgage-payment ratios are getting tighter, and sales are lingering as fewer buyers qualify for loans. Yet, unexpectedly, hard money rates haven’t increased much at this point due to intense competition. The facts that we’re exceptionally low leveraged and conservative are beneficial during these times.”

About Manhattan Bridge Capital, Inc.

Manhattan Bridge Capital, Inc. offers short-term secured, non–banking loans (sometimes referred to as ‘‘hard money’’ loans) to real estate investors to fund their acquisition, renovation, rehabilitation or development of properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida. The Company operates the website: https://www.manhattanbridgecapital.com.

Forward-Looking Statements

This press release and statements made by the Company’s representatives in connection with this press release contain, or may contain, forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are not statements of historical fact may be deemed to be forward-looking statements. Words such as “plan,” “project,” “potential,” “seek,” “may,” “will,” “expect,” “believe,” “anticipate,” “intend,” “could,” “estimate,” and “continue,” and similar expressions, are intended to identify forward-looking statements.

Forward-looking statements in this press release include, among other things, statements regarding the future lending activity, competitive conditions, and interest rates. Readers are cautioned that forward-looking statements are not guarantees of future performance and involve risks and uncertainties. Actual results may differ materially from those projected, expressed or implied in such forward-looking statements as a result of various factors, including, but not limited to: (i) our loan origination activities, revenues and profits are limited by available funds; (ii) we operate in a highly competitive market and competition may limit our ability to originate loans with favorable interest rates and fees; (iii) our Chief Executive Officer is critical to our business and our future success may depend on our ability to retain him; (iv) if we overestimate the yields on our loans or the amounts recoverable through foreclosure, or incorrectly value the collateral securing our loans, we may experience losses; (v) we may be subject to “lender liability” claims; (vi) our due diligence may not uncover all of a borrower’s liabilities or other risks to its business; (vii) borrower concentration could lead to significant losses; (viii) we may choose to make distributions in our own stock, in which case shareholders may be required to pay income taxes in excess of the cash dividends they receive; and (ix) an increase in interest rates may affect our profitability. The risk factors described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed with the Securities and Exchange Commission, identify additional important factors that could cause actual results to differ materially from those expressed or implied in any forward-looking statements. These forward-looking statements speak only as of the date of this press release. Except as required by applicable law, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

 
MANHATTAN BRIDGE CAPITAL, INC. AND SUBSIDIARY
CONSOLIDATED BALANCE SHEETS
       
Assets September 30, 2026
(unaudited)
  December 31, 2025
(audited)
Loans receivable, net of deferred origination and other fees $ 59,478,735     $ 60,218,841  
Interest and other fees receivable on loans   1,566,838       1,642,825  
Cash        
  168,093       204,889  
Cash – restricted   8,750       23,350  
Other assets   88,508       60,742  
Right-of-use asset – operating lease, net   61,616       101,226  
Deferred financing costs, net   107,000       98,858  
Total assets $ 61,479,540     $ 62,350,731  


Liabilities and Stockholders’ Equity      
Liabilities:      
Lines of credit $ 17,034,621     $ 17,601,132  
Accounts payable and accrued expenses   170,734       173,247  
Operating lease liability   69,274       112,076  
Loan holdback   164,598       50,000  
Dividends payable   1,250,834       1,314,732  
Total liabilities   18,690,061       19,251,187  
Commitments and contingencies      
       
Stockholders’ equity:      
Preferred shares - $.01 par value; 5,000,000 shares authorized; none issued and outstanding   ---       ---  
Common shares - $.001 par value; 25,000,000 shares authorized; 11,757,058 issued; 11,377,466 and 11,432,451 outstanding, respectively   11,757       11,757  
Additional paid-in capital   45,583,716       45,575,006  
Less: Treasury shares, at cost – 379,592 and 324,607 shares, respectively   (1,318,303 )     (1,098,964 )
Accumulated deficit   (1,487,691 )     (1,388,255 )
Total stockholders’ equity   42,789,479       43,099,544  
Total liabilities and stockholders’ equity $ 61,479,540     $ 62,350,731  
               


 
MANHATTAN BRIDGE CAPITAL, INC. AND SUBSIDIARY
CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited)
       
  Three Months
Ended September 30,
  Nine Months
Ended September 30,
  2026
  2025
  2026
  2025
Revenue:
Interest income from loans

$

1,661,896
   
$

1,770,377
   
$

5,099,291
   
$

5,503,694
 
Origination fees   391,662       265,376       1,067,114       1,161,008  
Total revenue   2,053,558       2,035,753       6,166,405       6,664,702  
                   
Operating costs and expenses:                  
Interest and amortization of deferred financing costs   369,477       421,980       1,131,684       1,379,595  
Referral fees   2,844       2,575       8,455       4,242  
General and administrative expenses   447,275       413,518       1,373,033       1,304,873  
Total operating costs and expenses   819,596       838,073       2,513,172       2,688,710  
Income from operations   1,233,962       1,197,680       3,653,233       3,975,992  
Other income   4,500       4,500       13,500       13,500  
Income before income tax expense   1,238,462       1,202,180       3,666,733       3,989,492  
Income tax expense   ---       ---       (1,300 )     (1,210 )
Net income $ 1,238,462     $ 1,202,180     $ 3,665,433     $ 3,988,282  
                   
Basic and diluted net income per common share outstanding:                  
--Basic $ 0.11     $ 0.11     $ 0.32     $ 0.35  
--Diluted $ 0.11     $ 0.11     $ 0.32     $ 0.35  
                   
Weighted average number of common shares outstanding:                  
--Basic   11,410,412       11,438,651       11,422,745       11,438,651  
--Diluted   11,410,412       11,438,651       11,422,745       11,438,651  
                               


 
MANHATTAN BRIDGE CAPITAL, INC. AND SUBSIDIARY
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY
(unaudited)
 
FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2026
  Common Shares Additional Paid in Capital Treasury Shares Accumulated Deficit Totals
  Shares Amount   Shares Cost    
Balance, July 1, 2026 11,757,058 $11,757 $45,581,538 331,549 $(1,129,013) $(1,475,319) $42,988,963
Non-cash compensation     2,178       2,178
Purchase of treasury shares       48,043 (189,290)   (189,290)
Dividends declared and payable           (1,250,834) (1,250,834)
Net income ________ ______ __________ ______ __________ 1,238,462 1,238,462
Balance, September 30, 2026 11,757,058 $11,757 $45,583,716 379,592 $(1,318,303) $(1,487,691) $42,789,479


FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2025
  Common Shares Additional Paid in Capital Treasury Shares Accumulated Deficit Totals
  Shares Amount   Shares Cost    
Balance, July 1, 2025 11,757,058 $11,757 $45,568,473 318,407 $(1,070,406) $(1,082,953) $43,426,871
Non-cash compensation     3,266       3,266
Dividends declared and payable           (1,315,445) (1,315,445)
Net income ________ ______ __________ ______ __________ 1,202,180 1,202,180
Balance, September 30, 2025 11,757,058 $11,757 $45,571,739 318,407 $(1,070,406) $(1,196,218) $43,316,872


FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2026
  Common Shares Additional Paid in Capital Treasury Shares Accumulated Deficit Totals
  Shares Amount   Shares Cost    
Balance, January 1, 2026 11,757,058 $11,757 $45,575,006 324,607 $(1,098,964) $ (1,388,255) $43,099,544
Non-cash compensation     8,710       8,710
Purchase of treasury shares       54,985 (219,339)   (219,339)
Dividends paid           (2,514,035) (2,514,035)
Dividends declared and payable           (1,250,834) (1,250,834)
Net income ________ ______ _________ ______ __________ 3,665,433 3,665,433
Balance, September 30, 2026 11,757,058 $11,757 $45,583,716 379,592 $(1,318,303) $(1,487,691) $42,789,479


FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2025
  Common Shares Additional Paid in Capital Treasury Shares Accumulated Deficit Totals
  Shares Amount   Shares Cost    
Balance, January 1, 2025 11,757,058 $11,757 $45,561,941 318,407 $(1,070,406) $(1,238,165) $43,265,127
Non-cash compensation     9,798       9,798
Dividends paid           (2,630,890) (2,630,890)
Dividends declared and payable           (1,315,445) (1,315,445)
Net income ________ ______ __________ ______ __________ 3,988,282 3,988,282
Balance, September 30, 2025 11,757,058 $11,757 $45,571,739 318,407 $(1,070,406) $(1,196,218) $43,316,872
               


 
MANHATTAN BRIDGE CAPITAL, INC. AND SUBSIDIARY
CONSOLIDATED STATEMENTS OF CASH FLOWS
(unaudited)
         
    Nine Months
Ended September 30,
    2026
  2025
Cash flows from operating activities:        
Net income   $ 3,665,433     $ 3,988,282  
Adjustments to reconcile net income to net cash provided by operating activities -        
Amortization of deferred financing costs     56,675       66,710  
Adjustment to right-of-use asset - operating lease and liability     (3,191 )     (1,459 )
Depreciation     1,281       4,007  
Non-cash compensation expense     8,710       9,798  
Changes in operating assets and liabilities:        
Interest and other fees receivable on loans     75,987       (70,895 )
Other assets     (29,049 )     (69,940 )
Accounts payable and accrued expenses     (2,513 )     (60,678 )
Deferred origination and other fees     138,546       (59,801 )
Proceeds from borrower escrow deposits – loan holdback     114,598       ---  
Net cash provided by operating activities     4,026,477       3,806,024  
         
Cash flows from investing activities:        
Issuance of short-term loans     (40,832,273 )     (27,957,494 )
Collections received from loans     41,433,833       35,474,993  
Purchase of fixed assets     ---       (418 )
Net cash provided by investing activities     601,560       7,517,081  
         
Cash flows from financing activities:        
Repayment of lines of credit     (43,901,366 )     (40,751,845 )
Proceeds from lines of credit     43,334,855       33,373,595  
Dividends paid     (3,828,767 )     (3,946,335 )
Purchase of treasury shares     (219,339 )     ---  
Deferred financing costs incurred     (64,816 )     ---  
Net cash used in financing activities     (4,679,433 )     (11,324,585 )
         
Net decrease in cash and restricted cash     (51,396 )     (1,480 )
Cash and restricted cash, beginning of period(1)     228,239       201,762  
Cash and restricted cash, end of period(2)   $ 176,843     $ 200,282  
         
Supplemental Disclosure of Cash Flow Information:        
Cash paid during the period for taxes   $ 1,300     $ 1,210  
Cash paid during the period for interest   $ 1,074,078     $ 1,346,361  
Cash paid during the period for operating leases   $ 49,454     $ 47,973  
         
Supplemental Schedule of Noncash Financing Activities:      
Dividend declared and payable   $ 1,250,834     $ 1,315,445  
       
Supplemental Schedule of Noncash Operating and Investing Activities:      
Reduction in interest receivable in connection with the increase in loans receivable   $ ---     $ 13,122  
                 

(1) At December 31, 2025 and 2024, cash and restricted cash included $23,350 and $23,750, respectively, of restricted cash.
(2) At September 30, 2026 and 2025, cash and restricted cash included $8,750 and $13,847, respectively, of restricted cash.

Contact:
Assaf Ran, CEO
(516) 444-3400
www.linkedin.com/in/assafran
SOURCE: Manhattan Bridge Capital, Inc.


Primary Logo

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The Albany Post

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.